Noticias de CRBP_US

06/05/2026 CRBP_US — MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day

06/05/2026 CRBP_US — Boston Real Estate Times

Colliers Facilitates Lease Renewal for Corbus Pharmaceuticals in Norwood

Norwood, Mass.— Colliers ha facilitado la renovación del contrato de arrendamiento de Corbus Pharmaceuticals Holdings, Inc. en 500 River Ridge Drive en Norwood, ampliando la presencia de la compañía en una oficina suburbana clave y […]

06/05/2026 CRBP_US — Colliers

Colliers Facilitates Lease Renewal for Corbus Pharmaceuticals at 500 River Ridge Drive in Norwood

05/05/2026 CRBP_US — MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day

05/05/2026 CRBP_US — Traders Union

Corbus Pharmaceuticals Holdings to unveil new CRB-701 clinical results at ASCO annual meeting

05/05/2026 CRBP_US — GlobeNewswire

Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026

Panel de KOL discutirá datos actualizados de monoterapia CRB-701 en HNSCC el 1 de junio de 2026...

05/05/2026 CRBP_US — MarketScreener

Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026

05/05/2026 CRBP_US — Stock Titan

Corbus to unpack 75-patient head and neck cancer data at June 1 ASCO panel

04/05/2026 CRBP_US — MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors despite daily gains

03/05/2026 CRBP_US — MarketBeat ES ← EN

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) recibió una calificación promedio de "compra moderada" por parte de las casas de bolsa

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Obtenga informe gratuito) ha recibido una calificación promedio de "Compra moderada" por parte de las once casas de bolsa que actualmente cubren la empresa, informa Marketbeat Ratings. Dos analistas de inversiones calificaron la acción con una recomendación de venta, siete tienen culo

01/05/2026 CRBP_US — MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day

01/05/2026 CRBP_US — MarketBeat ES ← EN

Calificación de acciones de Corbus Pharmaceuticals (NASDAQ:CRBP) mejorada por Guggenheim

Guggenheim mejoró a Corbus Pharmaceuticals a una calificación de "compra fuerte" en un informe de investigación el miércoles.

01/05/2026 CRBP_US — ChartMill

CRBP Stock Price, Quote & Chart | CORBUS PHARMACEUTICALS HOLDI (NASDAQ:CRBP)

29/04/2026 CRBP_US — MSN

Guggenheim initiates coverage of Corbus Pharmaceuticals Holdings (CRBP) with buy recommendation

29/04/2026 CRBP_US — Moomoo

Mizuho Adjusts Price Target on Corbus Pharmaceuticals to $40 From $39, Maintains Outperform Rating

29/04/2026 CRBP_US — MSN